After Apellis deal, Biogen looks to fill early-stage pipeline
Article
After Apellis deal, Biogen looks to fill early-stage pipeline
Source
Biogen is still looking at deals even after earmarking $5.6 billion to buy Apellis Pharmaceuticals earlier this month. “Most of what we're going to be focusing on is early-stage development and research, because that part ...
Related
10 events DateTypeEvent
Apr 28 ScanBiotech Scan Apr 28 ScanHealthcare Scan May 1 ArticleChannel Beats SKU — Does the GLP-1 Distribution Thesis Generalize? Apr 26 ScanHealthcare Scan Apr 26 ScanBiotech Scan Apr 13 Scan2 — HEALTHCARE SCAN Apr 13 Scan1 — BIOTECH SCAN Apr 10 ScanBiotech Scan Apr 10 ScanHealthcare Scan Apr 3 ScanHealthcare Scan Source links
Tweets, videos, filings, articles, and source pages tied to this read.
endpoints.newsendpoints.news